Abstract:Importance: Pulmonary embolism (PE) is characterized by occlusion of blood flow in a pulmonary artery, typically due to a thrombus that travels from a vein in a lower limb. The incidence of PE is approximately 60 to 120 per 100 000 people per year. Approximately 60 000 to 100 000 patients die from PE each year in the US. Observations: PE should be considered in patients presenting with acute chest pain, shortness of breath, or syncope. The diagnosis is determined by chest imaging. In patients with a systolic blood pressure of at least 90 mm Hg, the following 3 steps can be used to evaluate a patient with possible PE: assessment of the clinical probability of PE, D-dimer testing if indicated, and chest imaging if indicated. The clinical probability of PE can be assessed using a structured score or using clinical gestalt. In patients with a probability of PE that is less than 15%, the presence of 8 clinical characteristics (age <50 years, heart rate <100/min, an oxygen saturation level of > 94%, no recent surgery or trauma, no prior venous thromboembolism event, no hemoptysis, no unilateral leg swelling, and no estrogen use) identifies patients at very low risk of PE in whom no further testing is needed. In patients with low or intermediate clinical probability, a D-dimer level of less than 500 ng/mL is associated with a posttest probability of PE less than 1.85%. In these patients, PE can be excluded without chest imaging. A further refinement of D-dimer threshold is possible in patients aged 50 years and older, and in patients with a low likelihood of PE. Patients with a high probability of PE (ie, >40% probability) should undergo chest imaging, and D-dimer testing is not necessary. In patients with PE and a systolic blood pressure of 90 mm Hg or higher, compared with heparin combined with a vitamin K antagonist such as warfarin followed by warfarin alone, direct oral anticoagulants such as apixaban, edoxaban, rivaroxaban, or dabigatran, are noninferior for treating PE and have a 0.6% lower rate of bleeding. In patients with PE and systolic blood pressure lower than 90 mm Hg, systemic thrombolysis is recommended and is associated with an 1.6% absolute reduction of mortality (from 3.9% to 2.3%). Conclusions and relevance: In the US, PE affects approximately 370 000 patients per year and may cause approximately 60 000 to 100 000 deaths per year. First-line therapy consists of direct oral anticoagulants such as apixaban, edoxaban, rivaroxaban, or dabigatran, with thrombolysis reserved for patients with systolic blood pressure lower than 90 mm Hg.

Acute symptomatic pulmonary embolism associated with long haul air travel to Sydney

Severe pulmonary embolism associated with air travel

Clinical analysis of acute pulmonary embolism in 49 cases

Aeromedical Retrieval of Critically Ill Pulmonary Embolism Patients: A Protocol for a Retrospective Cohort Study of 10 Years in New South Wales

COVID-19, long flights, and deep vein thrombosis: What we know so far

Symptoms Suggestive of Postpulmonary Embolism Syndrome and Utilization of Diagnostic Testing

GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011

Travel-weary to travel-worry: the epidemiology of injury-related traveller deaths in Australia, 2006-2017

Epidemiology, Etiology, and Pathophysiology of Pulmonary Embolism

Medical emergencies at a major international airport: in-flight symptoms and ground-based follow-up

Travel-associated illness in children in pre-pandemic Western Sydney, 2018-2020

Travel-associated illness in older adults (>60 y)

Clinical Presentation and Risk Stratification of Pulmonary Embolism

Acute Pulmonary Embolism: A Review

Outpatient Management of Patients Following Diagnosis of Acute Pulmonary Embolism

Incidence of Pleural Effusion in Patients with Pulmonary Embolism

A case of cerebral aneurysm rupture and subarachnoid hemorrhage associated with air travel

[Pulmonary embolism: an analysis of 25 patients]

Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients

Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period

Overuse of Computed Tomography Pulmonary Angiography and Low Utilization of Clinical Prediction Rules in Suspected Pulmonary Embolism Patients at a Regional Australian Hospital